7.4. Exposure in equity investments and capital instruments

The accompanying table shows the types, nature and amounts of the original exposures in equity investments listed or unlisted on a stock market, with an item differentiating sufficiently diversified portfolios and other unlisted instruments.

2012

(Million euros)

	Type of exposure (1)
Item	Non-derivatives	Derivatives
Exchange-traded instruments	3,547	94
Non-exchange traded instruments	2,608	-15
Included in sufficiently diversified portfolios	2,608	-15
Other non-traded instruments	-	-
TOTAL EQUITY POSITIONS	6,155	79

(1) Depending on their nature, equity instruments not included in Trading Book Activity will be separated into derivatives and non-derivatives. The amount shown refers to original exposure, i.e. gross exposure of value corrections through asset impairment and provisions, before applying risk mitigation techniques.

2011

(Million euros)

	Type of exposure (1)
Item	Non-derivatives	Non-derivatives
Exchange-traded instruments	4,434	27
Non-exchange traded instruments	1,974	-10
Included in sufficiently diversified portfolios	1,974	-10
Other non-traded instruments	0	0
TOTAL EQUITY POSITIONS	6,409	17

(1) Depending on their nature, equity instruments not included in Trading Book Activity will be separated into derivatives and non-derivatives. The amount shown refers to original exposure, i.e. gross exposure of value corrections through asset impairment and provisions, before applying risk mitigation techniques.

The amount of profits recorded as a result of the sale or liquidation of capital instruments or equity investments was €49 million as of December 31, 2012 and €108 million as of December 31, 2011. The amounts recorded in equity were a loss of €125 million as of December 31, 2012 and a profit of €372 million as of December 31, 2011.